

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 8.69187860 |
| 2 | renal absorption (GO:0070293) | 7.02093561 |
| 3 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 6.47439462 |
| 4 | positive regulation of receptor biosynthetic process (GO:0010870) | 6.27657994 |
| 5 | drug transmembrane transport (GO:0006855) | 6.03069318 |
| 6 | urate metabolic process (GO:0046415) | 5.89100962 |
| 7 | regulation of lipoprotein particle clearance (GO:0010984) | 5.68483981 |
| 8 | peptide catabolic process (GO:0043171) | 5.66131102 |
| 9 | sensory perception of smell (GO:0007608) | 5.62987614 |
| 10 | imidazole-containing compound metabolic process (GO:0052803) | 5.59885119 |
| 11 | high-density lipoprotein particle remodeling (GO:0034375) | 5.48867548 |
| 12 | cell wall macromolecule catabolic process (GO:0016998) | 5.29260482 |
| 13 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.19722576 |
| 14 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 5.09836650 |
| 15 | nitric oxide mediated signal transduction (GO:0007263) | 4.92931422 |
| 16 | drug transport (GO:0015893) | 4.86794797 |
| 17 | reverse cholesterol transport (GO:0043691) | 4.86457164 |
| 18 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.77203983 |
| 19 | phosphate ion transport (GO:0006817) | 4.73994804 |
| 20 | hydrogen peroxide catabolic process (GO:0042744) | 4.67422682 |
| 21 | phospholipid efflux (GO:0033700) | 4.65174655 |
| 22 | regulation of cholesterol esterification (GO:0010872) | 4.62696646 |
| 23 | glutathione biosynthetic process (GO:0006750) | 4.59422190 |
| 24 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.57360080 |
| 25 | protein-lipid complex assembly (GO:0065005) | 4.49910676 |
| 26 | cell wall macromolecule metabolic process (GO:0044036) | 4.47105452 |
| 27 | cholesterol efflux (GO:0033344) | 4.44526659 |
| 28 | organic cation transport (GO:0015695) | 4.43220638 |
| 29 | plasma lipoprotein particle assembly (GO:0034377) | 4.39732804 |
| 30 | nephron tubule morphogenesis (GO:0072078) | 4.39193143 |
| 31 | nephron epithelium morphogenesis (GO:0072088) | 4.39193143 |
| 32 | positive regulation of antigen processing and presentation (GO:0002579) | 4.32962462 |
| 33 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.30506723 |
| 34 | nephron tubule formation (GO:0072079) | 4.23427612 |
| 35 | negative regulation of sterol transport (GO:0032372) | 4.15913464 |
| 36 | negative regulation of cholesterol transport (GO:0032375) | 4.15913464 |
| 37 | regulation of RIG-I signaling pathway (GO:0039535) | 4.11153518 |
| 38 | positive regulation of tolerance induction (GO:0002645) | 4.01689176 |
| 39 | response to lipoprotein particle (GO:0055094) | 4.01547857 |
| 40 | lysine catabolic process (GO:0006554) | 3.95775389 |
| 41 | lysine metabolic process (GO:0006553) | 3.95775389 |
| 42 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 3.94025953 |
| 43 | excretion (GO:0007588) | 3.90704967 |
| 44 | response to mercury ion (GO:0046689) | 3.88342776 |
| 45 | biotin metabolic process (GO:0006768) | 3.87426383 |
| 46 | positive regulation of granulocyte chemotaxis (GO:0071624) | 3.86918505 |
| 47 | regulation of receptor biosynthetic process (GO:0010869) | 3.83967279 |
| 48 | myeloid dendritic cell differentiation (GO:0043011) | 3.81307990 |
| 49 | NIK/NF-kappaB signaling (GO:0038061) | 3.78565396 |
| 50 | phosphatidylcholine biosynthetic process (GO:0006656) | 3.78067168 |
| 51 | regulation of regulatory T cell differentiation (GO:0045589) | 3.77023518 |
| 52 | protein-lipid complex remodeling (GO:0034368) | 3.72861807 |
| 53 | macromolecular complex remodeling (GO:0034367) | 3.72861807 |
| 54 | plasma lipoprotein particle remodeling (GO:0034369) | 3.72861807 |
| 55 | piRNA metabolic process (GO:0034587) | 3.72413666 |
| 56 | neurotransmitter catabolic process (GO:0042135) | 3.71149985 |
| 57 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.67755588 |
| 58 | negative regulation of lipase activity (GO:0060192) | 3.67591636 |
| 59 | intestinal cholesterol absorption (GO:0030299) | 3.66898503 |
| 60 | superoxide anion generation (GO:0042554) | 3.65866774 |
| 61 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.65838621 |
| 62 | ovulation from ovarian follicle (GO:0001542) | 3.65727580 |
| 63 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.62562489 |
| 64 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.61828124 |
| 65 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.60793787 |
| 66 | peptide biosynthetic process (GO:0043043) | 3.55996082 |
| 67 | axoneme assembly (GO:0035082) | 3.55357936 |
| 68 | keratinocyte development (GO:0003334) | 3.50222810 |
| 69 | macroautophagy (GO:0016236) | 3.49681103 |
| 70 | dendritic cell differentiation (GO:0097028) | 3.48045114 |
| 71 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.47450386 |
| 72 | negative regulation of interleukin-10 production (GO:0032693) | 3.38882138 |
| 73 | phosphate ion homeostasis (GO:0055062) | 3.38843744 |
| 74 | trivalent inorganic anion homeostasis (GO:0072506) | 3.38843744 |
| 75 | diterpenoid biosynthetic process (GO:0016102) | 3.38843493 |
| 76 | endocrine pancreas development (GO:0031018) | 3.38157252 |
| 77 | regulation of antigen processing and presentation (GO:0002577) | 3.37876836 |
| 78 | protein localization to cilium (GO:0061512) | 3.36709541 |
| 79 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.35962025 |
| 80 | lung vasculature development (GO:0060426) | 3.35440329 |
| 81 | pericardium development (GO:0060039) | 3.35046400 |
| 82 | phosphate ion transmembrane transport (GO:0035435) | 3.33987536 |
| 83 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.33055186 |
| 84 | magnesium ion transport (GO:0015693) | 3.30139011 |
| 85 | renal tubule morphogenesis (GO:0061333) | 3.26988909 |
| 86 | response to thyroid hormone (GO:0097066) | 3.26026744 |
| 87 | mitochondrial calcium ion transport (GO:0006851) | 3.26013782 |
| 88 | glyoxylate metabolic process (GO:0046487) | 3.25035814 |
| 89 | sodium-independent organic anion transport (GO:0043252) | 3.24890725 |
| 90 | regulation of glucokinase activity (GO:0033131) | 3.24846944 |
| 91 | regulation of hexokinase activity (GO:1903299) | 3.24846944 |
| 92 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 3.22419519 |
| 93 | embryonic heart tube development (GO:0035050) | 3.20294777 |
| 94 | vitamin transmembrane transport (GO:0035461) | 3.19140218 |
| 95 | response to nitric oxide (GO:0071731) | 3.19134803 |
| 96 | tongue development (GO:0043586) | 3.18764750 |
| 97 | quaternary ammonium group transport (GO:0015697) | 3.18004610 |
| 98 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.17880025 |
| 99 | branched-chain amino acid metabolic process (GO:0009081) | 3.17257070 |
| 100 | sensory perception of chemical stimulus (GO:0007606) | 3.17082240 |
| 101 | myelin maintenance (GO:0043217) | 3.16253162 |
| 102 | nucleoside diphosphate catabolic process (GO:0009134) | 3.14812438 |
| 103 | plasma lipoprotein particle clearance (GO:0034381) | 3.14139641 |
| 104 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.13154582 |
| 105 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.12301742 |
| 106 | tricarboxylic acid metabolic process (GO:0072350) | 3.12270330 |
| 107 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.11963324 |
| 108 | response to hepatocyte growth factor (GO:0035728) | 3.11963324 |
| 109 | chemosensory behavior (GO:0007635) | 3.11942012 |
| 110 | cilium movement (GO:0003341) | 3.10863017 |
| 111 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.10012592 |
| 112 | protein-lipid complex subunit organization (GO:0071825) | 3.09946788 |
| 113 | negative regulation of gluconeogenesis (GO:0045721) | 3.09939196 |
| 114 | negative regulation of metanephros development (GO:0072217) | 3.08543508 |
| 115 | L-ascorbic acid metabolic process (GO:0019852) | 3.08464280 |
| 116 | oxygen transport (GO:0015671) | 3.08299877 |
| 117 | drug catabolic process (GO:0042737) | 3.07869748 |
| 118 | desmosome organization (GO:0002934) | 3.07110000 |
| 119 | DNA methylation involved in gamete generation (GO:0043046) | 3.06685230 |
| 120 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.06458233 |
| 121 | axonemal dynein complex assembly (GO:0070286) | 3.06001207 |
| 122 | thyroid hormone generation (GO:0006590) | 3.05854850 |
| 123 | short-chain fatty acid metabolic process (GO:0046459) | 3.05650141 |
| 124 | lipoprotein metabolic process (GO:0042157) | 3.05518998 |
| 125 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.04041994 |
| 126 | cellular ketone body metabolic process (GO:0046950) | 3.03518487 |
| 127 | exogenous drug catabolic process (GO:0042738) | 3.00687074 |
| 128 | oligosaccharide catabolic process (GO:0009313) | 3.00554587 |
| 129 | epithelial cilium movement (GO:0003351) | 2.99948279 |
| 130 | chemical homeostasis within a tissue (GO:0048875) | 2.99183443 |
| 131 | hydrogen peroxide metabolic process (GO:0042743) | 2.98431733 |
| 132 | cholesterol transport (GO:0030301) | 2.97717013 |
| 133 | sterol transport (GO:0015918) | 2.97717013 |
| 134 | cysteine metabolic process (GO:0006534) | 2.97042941 |
| 135 | cellular response to vitamin D (GO:0071305) | 2.96559779 |
| 136 | response to magnesium ion (GO:0032026) | 2.96539058 |
| 137 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.95940629 |
| 138 | male meiosis I (GO:0007141) | 2.95789143 |
| 139 | plasma lipoprotein particle organization (GO:0071827) | 2.95663764 |
| 140 | myeloid dendritic cell activation (GO:0001773) | 2.93852125 |
| 141 | regulation of meiosis I (GO:0060631) | 2.91827611 |
| 142 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.91466839 |
| 143 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.91153433 |
| 144 | leukotriene biosynthetic process (GO:0019370) | 2.90902209 |
| 145 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.83692849 |
| 146 | hypothalamus development (GO:0021854) | 2.83399425 |
| 147 | fibroblast migration (GO:0010761) | 2.82498144 |
| 148 | low-density lipoprotein particle remodeling (GO:0034374) | 2.82296975 |
| 149 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.79033399 |
| 150 | protein targeting to Golgi (GO:0000042) | 2.77274902 |
| 151 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.76887936 |
| 152 | cellular response to pH (GO:0071467) | 2.76538134 |
| 153 | regulation of T cell tolerance induction (GO:0002664) | 2.75650558 |
| 154 | glutathione derivative biosynthetic process (GO:1901687) | 2.73674291 |
| 155 | glutathione derivative metabolic process (GO:1901685) | 2.73674291 |
| 156 | acylglycerol homeostasis (GO:0055090) | 2.73432096 |
| 157 | triglyceride homeostasis (GO:0070328) | 2.73432096 |
| 158 | iron coordination entity transport (GO:1901678) | 2.72861200 |
| 159 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.72623672 |
| 160 | positive regulation of neutrophil migration (GO:1902624) | 2.72623672 |
| 161 | activation of Rac GTPase activity (GO:0032863) | 2.70920752 |
| 162 | surfactant homeostasis (GO:0043129) | 2.68919633 |
| 163 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.68844288 |
| 164 | regulation of endothelial cell differentiation (GO:0045601) | 2.68661605 |
| 165 | vitamin D metabolic process (GO:0042359) | 2.68184913 |
| 166 | positive regulation of glycolytic process (GO:0045821) | 2.67964872 |
| 167 | male meiosis (GO:0007140) | 2.67486361 |
| 168 | homocysteine metabolic process (GO:0050667) | 2.67240177 |
| 169 | establishment of protein localization to Golgi (GO:0072600) | 2.66382506 |
| 170 | L-phenylalanine catabolic process (GO:0006559) | 2.66353129 |
| 171 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.66353129 |
| 172 | histone H3-K9 demethylation (GO:0033169) | 2.66204840 |
| 173 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.65919487 |
| 174 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.64504224 |
| 175 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 2.64047465 |
| 176 | embryonic digestive tract development (GO:0048566) | 2.63670277 |
| 177 | L-phenylalanine metabolic process (GO:0006558) | 2.63652520 |
| 178 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.63652520 |
| 179 | ovulation (GO:0030728) | 2.63376035 |
| 180 | metanephric tubule development (GO:0072170) | 2.63081095 |
| 181 | metanephric nephron tubule development (GO:0072234) | 2.63081095 |
| 182 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.62845334 |
| 183 | cellular modified amino acid catabolic process (GO:0042219) | 2.62733847 |
| 184 | valine metabolic process (GO:0006573) | 2.62313539 |
| 185 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.62129073 |
| 186 | galactose metabolic process (GO:0006012) | 2.61220512 |
| 187 | protein localization to Golgi apparatus (GO:0034067) | 2.60787092 |
| 188 | terpenoid biosynthetic process (GO:0016114) | 2.60204749 |
| 189 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.59776185 |
| 190 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 2.59727259 |
| 191 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.57649397 |
| 192 | cellular response to vitamin (GO:0071295) | 2.55585213 |
| 193 | cell adhesion mediated by integrin (GO:0033627) | 2.55477414 |
| 194 | renal tubule development (GO:0061326) | 2.54025341 |
| 195 | aspartate family amino acid catabolic process (GO:0009068) | 2.54000763 |
| 196 | cellular response to exogenous dsRNA (GO:0071360) | 2.53312672 |
| 197 | metanephric nephron epithelium development (GO:0072243) | 2.52808802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.36576955 |
| 2 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 3.34071891 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.10096435 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.05022439 |
| 5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.01885305 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.96416452 |
| 7 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.81912846 |
| 8 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.74235788 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.62811487 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.57727723 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.57300535 |
| 12 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.46846191 |
| 13 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.43677863 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.30464387 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.24075334 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.22675267 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.19909459 |
| 18 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.07029288 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.03536199 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.98563197 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.96016926 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.93381527 |
| 23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.89040291 |
| 24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.82289113 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.77667878 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.77527298 |
| 27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.76088183 |
| 28 | TP53_16413492_ChIP-PET_HCT116_Human | 1.75576097 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.74066036 |
| 30 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.71937168 |
| 31 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.70552371 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.63671400 |
| 33 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.63021226 |
| 34 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.61614125 |
| 35 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.61233026 |
| 36 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.60840130 |
| 37 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.58323683 |
| 38 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.56767665 |
| 39 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.53859952 |
| 40 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.50738725 |
| 41 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.47906662 |
| 42 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.45472647 |
| 43 | STAT3_23295773_ChIP-Seq_U87_Human | 1.44493550 |
| 44 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.42574920 |
| 45 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42307831 |
| 46 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.41957200 |
| 47 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.40719251 |
| 48 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.40477932 |
| 49 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.38339773 |
| 50 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.38230555 |
| 51 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.33896667 |
| 52 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.33340494 |
| 53 | ERA_21632823_ChIP-Seq_H3396_Human | 1.33316479 |
| 54 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.32527071 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.32025237 |
| 56 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.30981164 |
| 57 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.30665947 |
| 58 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.29271631 |
| 59 | TCF4_23295773_ChIP-Seq_U87_Human | 1.28988203 |
| 60 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.27894772 |
| 61 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.27793855 |
| 62 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.24898791 |
| 63 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.23103776 |
| 64 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.22040473 |
| 65 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.18843482 |
| 66 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18606263 |
| 67 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.18048717 |
| 68 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.17054006 |
| 69 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.16843419 |
| 70 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.16284959 |
| 71 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.16156379 |
| 72 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.15296947 |
| 73 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.14015674 |
| 74 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.12612629 |
| 75 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.12612629 |
| 76 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.11291994 |
| 77 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.09439437 |
| 78 | AR_20517297_ChIP-Seq_VCAP_Human | 1.09266919 |
| 79 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09061452 |
| 80 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.09014140 |
| 81 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.08548966 |
| 82 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07326818 |
| 83 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.05379246 |
| 84 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.05379246 |
| 85 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.05335471 |
| 86 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05064458 |
| 87 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.03721839 |
| 88 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.03332123 |
| 89 | AR_25329375_ChIP-Seq_VCAP_Human | 1.03281994 |
| 90 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03024104 |
| 91 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.02978402 |
| 92 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02877801 |
| 93 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.02755191 |
| 94 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.02567045 |
| 95 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.02310025 |
| 96 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02296592 |
| 97 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01425945 |
| 98 | CJUN_26792858_Chip-Seq_BT549_Human | 1.00996327 |
| 99 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00959110 |
| 100 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00696394 |
| 101 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.00412390 |
| 102 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99620097 |
| 103 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99248547 |
| 104 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98783800 |
| 105 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.97799679 |
| 106 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97780657 |
| 107 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.96764679 |
| 108 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96326281 |
| 109 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.95970326 |
| 110 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.95624374 |
| 111 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.95018280 |
| 112 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94133995 |
| 113 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.93596573 |
| 114 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.93034395 |
| 115 | * CBP_20019798_ChIP-Seq_JUKART_Human | 0.92984275 |
| 116 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.92984275 |
| 117 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.92956580 |
| 118 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.92825781 |
| 119 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.92825781 |
| 120 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.92576907 |
| 121 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.92576907 |
| 122 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92527144 |
| 123 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.91976265 |
| 124 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.91744438 |
| 125 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.91316203 |
| 126 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.91118082 |
| 127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90658993 |
| 128 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.90643274 |
| 129 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.90519589 |
| 130 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90482953 |
| 131 | P300_19829295_ChIP-Seq_ESCs_Human | 0.89328103 |
| 132 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.89191447 |
| 133 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88782693 |
| 134 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.88344232 |
| 135 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.88333145 |
| 136 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88116610 |
| 137 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.87874849 |
| 138 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.87206518 |
| 139 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.87123918 |
| 140 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.86837873 |
| 141 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.86728096 |
| 142 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.86664355 |
| 143 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.86308713 |
| 144 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.85753229 |
| 145 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84208810 |
| 146 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84208810 |
| 147 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.83759083 |
| 148 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.83189869 |
| 149 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.81622301 |
| 150 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80762991 |
| 151 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.80051729 |
| 152 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.79725973 |
| 153 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.79190926 |
| 154 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77947985 |
| 155 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.77812574 |
| 156 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.77754913 |
| 157 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77429306 |
| 158 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.76901445 |
| 159 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76858443 |
| 160 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.76827735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 6.55970609 |
| 2 | MP0002876_abnormal_thyroid_physiology | 6.11280651 |
| 3 | MP0005645_abnormal_hypothalamus_physiol | 5.88551290 |
| 4 | MP0001984_abnormal_olfaction | 3.54461645 |
| 5 | MP0002877_abnormal_melanocyte_morpholog | 3.31476653 |
| 6 | MP0000685_abnormal_immune_system | 3.27653202 |
| 7 | MP0005360_urolithiasis | 3.08363028 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 3.00975074 |
| 9 | MP0003123_paternal_imprinting | 2.99999474 |
| 10 | MP0004043_abnormal_pH_regulation | 2.90307269 |
| 11 | MP0001348_abnormal_lacrimal_gland | 2.86375237 |
| 12 | MP0003879_abnormal_hair_cell | 2.85551954 |
| 13 | MP0009840_abnormal_foam_cell | 2.77657866 |
| 14 | MP0000678_abnormal_parathyroid_gland | 2.77279107 |
| 15 | MP0003195_calcinosis | 2.67226602 |
| 16 | MP0001346_abnormal_lacrimal_gland | 2.64717688 |
| 17 | MP0005310_abnormal_salivary_gland | 2.62223965 |
| 18 | MP0000013_abnormal_adipose_tissue | 2.58488921 |
| 19 | MP0009643_abnormal_urine_homeostasis | 2.53665973 |
| 20 | MP0010329_abnormal_lipoprotein_level | 2.41346194 |
| 21 | MP0005332_abnormal_amino_acid | 2.39218192 |
| 22 | MP0001756_abnormal_urination | 2.35543452 |
| 23 | MP0001835_abnormal_antigen_presentation | 2.28874696 |
| 24 | MP0008877_abnormal_DNA_methylation | 2.17969170 |
| 25 | MP0004510_myositis | 2.13389748 |
| 26 | MP0005083_abnormal_biliary_tract | 2.09202187 |
| 27 | MP0006082_CNS_inflammation | 2.04894497 |
| 28 | MP0000003_abnormal_adipose_tissue | 1.94382116 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 1.90045507 |
| 30 | MP0001764_abnormal_homeostasis | 1.88199683 |
| 31 | MP0001666_abnormal_nutrient_absorption | 1.83488342 |
| 32 | MP0001873_stomach_inflammation | 1.82818790 |
| 33 | MP0002909_abnormal_adrenal_gland | 1.80291155 |
| 34 | MP0002136_abnormal_kidney_physiology | 1.77265472 |
| 35 | MP0002163_abnormal_gland_morphology | 1.74090027 |
| 36 | MP0003959_abnormal_lean_body | 1.72596462 |
| 37 | MP0000538_abnormal_urinary_bladder | 1.71353574 |
| 38 | MP0002277_abnormal_respiratory_mucosa | 1.68889101 |
| 39 | MP0005670_abnormal_white_adipose | 1.66774245 |
| 40 | MP0002132_abnormal_respiratory_system | 1.66750317 |
| 41 | MP0001765_abnormal_ion_homeostasis | 1.66583597 |
| 42 | MP0003878_abnormal_ear_physiology | 1.58897133 |
| 43 | MP0005377_hearing/vestibular/ear_phenot | 1.58897133 |
| 44 | MP0003252_abnormal_bile_duct | 1.53434054 |
| 45 | MP0000566_synostosis | 1.52295075 |
| 46 | MP0002928_abnormal_bile_duct | 1.48050026 |
| 47 | MP0005408_hypopigmentation | 1.43134518 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.42616701 |
| 49 | MP0003283_abnormal_digestive_organ | 1.40905648 |
| 50 | MP0006054_spinal_hemorrhage | 1.38688150 |
| 51 | MP0008004_abnormal_stomach_pH | 1.37997297 |
| 52 | MP0005646_abnormal_pituitary_gland | 1.37119259 |
| 53 | MP0000639_abnormal_adrenal_gland | 1.35705509 |
| 54 | MP0002139_abnormal_hepatobiliary_system | 1.35061275 |
| 55 | MP0003638_abnormal_response/metabolism_ | 1.33388830 |
| 56 | MP0005551_abnormal_eye_electrophysiolog | 1.31810875 |
| 57 | MP0005220_abnormal_exocrine_pancreas | 1.28942585 |
| 58 | MP0003122_maternal_imprinting | 1.25538006 |
| 59 | MP0004133_heterotaxia | 1.25152823 |
| 60 | MP0009333_abnormal_splenocyte_physiolog | 1.22165329 |
| 61 | MP0010234_abnormal_vibrissa_follicle | 1.21956916 |
| 62 | MP0001485_abnormal_pinna_reflex | 1.21609625 |
| 63 | MP0005636_abnormal_mineral_homeostasis | 1.21230795 |
| 64 | MP0005084_abnormal_gallbladder_morpholo | 1.18994369 |
| 65 | MP0002735_abnormal_chemical_nociception | 1.17904805 |
| 66 | MP0001944_abnormal_pancreas_morphology | 1.14238967 |
| 67 | MP0000372_irregular_coat_pigmentation | 1.13601118 |
| 68 | MP0001853_heart_inflammation | 1.13274818 |
| 69 | MP0003953_abnormal_hormone_level | 1.12549150 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 1.11651006 |
| 71 | MP0004264_abnormal_extraembryonic_tissu | 1.11059888 |
| 72 | MP0001879_abnormal_lymphatic_vessel | 1.11032168 |
| 73 | MP0009780_abnormal_chondrocyte_physiolo | 1.10180151 |
| 74 | MP0002118_abnormal_lipid_homeostasis | 1.09161286 |
| 75 | MP0000383_abnormal_hair_follicle | 1.09068626 |
| 76 | MP0001958_emphysema | 1.08858748 |
| 77 | MP0001502_abnormal_circadian_rhythm | 1.06978858 |
| 78 | MP0005389_reproductive_system_phenotype | 1.05302649 |
| 79 | MP0005379_endocrine/exocrine_gland_phen | 1.03865817 |
| 80 | MP0000516_abnormal_urinary_system | 1.03288523 |
| 81 | MP0005367_renal/urinary_system_phenotyp | 1.03288523 |
| 82 | MP0005671_abnormal_response_to | 1.01450586 |
| 83 | MP0002938_white_spotting | 0.96722197 |
| 84 | MP0009764_decreased_sensitivity_to | 0.94202992 |
| 85 | MP0002971_abnormal_brown_adipose | 0.88549631 |
| 86 | MP0008875_abnormal_xenobiotic_pharmacok | 0.88150428 |
| 87 | MP0001929_abnormal_gametogenesis | 0.86292717 |
| 88 | MP0005395_other_phenotype | 0.85780887 |
| 89 | MP0008874_decreased_physiological_sensi | 0.85561189 |
| 90 | MP0003787_abnormal_imprinting | 0.84749349 |
| 91 | MP0001919_abnormal_reproductive_system | 0.84242349 |
| 92 | MP0002210_abnormal_sex_determination | 0.83740286 |
| 93 | MP0005085_abnormal_gallbladder_physiolo | 0.83208184 |
| 94 | MP0002557_abnormal_social/conspecific_i | 0.82795138 |
| 95 | MP0003011_delayed_dark_adaptation | 0.82666535 |
| 96 | MP0010386_abnormal_urinary_bladder | 0.81831282 |
| 97 | MP0001664_abnormal_digestion | 0.81658126 |
| 98 | MP0005375_adipose_tissue_phenotype | 0.81501423 |
| 99 | MP0003698_abnormal_male_reproductive | 0.80811416 |
| 100 | MP0001270_distended_abdomen | 0.80533027 |
| 101 | MP0004885_abnormal_endolymph | 0.80381945 |
| 102 | MP0008872_abnormal_physiological_respon | 0.80219214 |
| 103 | MP0003941_abnormal_skin_development | 0.80040227 |
| 104 | MP0003936_abnormal_reproductive_system | 0.78876270 |
| 105 | MP0009046_muscle_twitch | 0.78846819 |
| 106 | MP0003656_abnormal_erythrocyte_physiolo | 0.77793786 |
| 107 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77514518 |
| 108 | MP0008995_early_reproductive_senescence | 0.77375329 |
| 109 | MP0003075_altered_response_to | 0.77089761 |
| 110 | MP0005647_abnormal_sex_gland | 0.76671135 |
| 111 | MP0001145_abnormal_male_reproductive | 0.74755610 |
| 112 | MP0003943_abnormal_hepatobiliary_system | 0.73757706 |
| 113 | MP0001324_abnormal_eye_pigmentation | 0.73178017 |
| 114 | MP0003938_abnormal_ear_development | 0.72725903 |
| 115 | MP0000653_abnormal_sex_gland | 0.72591869 |
| 116 | MP0005253_abnormal_eye_physiology | 0.72163620 |
| 117 | MP0002078_abnormal_glucose_homeostasis | 0.72094250 |
| 118 | MP0005319_abnormal_enzyme/_coenzyme | 0.72055147 |
| 119 | MP0002896_abnormal_bone_mineralization | 0.71576963 |
| 120 | MP0005410_abnormal_fertilization | 0.70702769 |
| 121 | MP0010352_gastrointestinal_tract_polyps | 0.70090633 |
| 122 | MP0003136_yellow_coat_color | 0.69565987 |
| 123 | MP0002160_abnormal_reproductive_system | 0.68525441 |
| 124 | MP0009115_abnormal_fat_cell | 0.67721000 |
| 125 | MP0005387_immune_system_phenotype | 0.67565356 |
| 126 | MP0001790_abnormal_immune_system | 0.67565356 |
| 127 | MP0003890_abnormal_embryonic-extraembry | 0.66590772 |
| 128 | MP0001542_abnormal_bone_strength | 0.66349400 |
| 129 | MP0005058_abnormal_lysosome_morphology | 0.64022573 |
| 130 | MP0001845_abnormal_inflammatory_respons | 0.63513046 |
| 131 | MP0001663_abnormal_digestive_system | 0.62987589 |
| 132 | MP0002168_other_aberrant_phenotype | 0.61499585 |
| 133 | MP0003186_abnormal_redox_activity | 0.60064780 |
| 134 | MP0010155_abnormal_intestine_physiology | 0.59981173 |
| 135 | MP0001851_eye_inflammation | 0.58812888 |
| 136 | MP0004147_increased_porphyrin_level | 0.57598176 |
| 137 | MP0000470_abnormal_stomach_morphology | 0.56238367 |
| 138 | MP0003045_fibrosis | 0.55691784 |
| 139 | MP0004484_altered_response_of | 0.55363517 |
| 140 | MP0005623_abnormal_meninges_morphology | 0.54946771 |
| 141 | MP0002135_abnormal_kidney_morphology | 0.52935105 |
| 142 | MP0005365_abnormal_bile_salt | 0.52423562 |
| 143 | MP0001501_abnormal_sleep_pattern | 0.50958240 |
| 144 | MP0001963_abnormal_hearing_physiology | 0.50441239 |
| 145 | MP0008469_abnormal_protein_level | 0.50345541 |
| 146 | MP0000681_abnormal_thyroid_gland | 0.49787486 |
| 147 | MP0001881_abnormal_mammary_gland | 0.49098441 |
| 148 | MP0003183_abnormal_peptide_metabolism | 0.48958493 |
| 149 | MP0002734_abnormal_mechanical_nocicepti | 0.48288294 |
| 150 | MP0003724_increased_susceptibility_to | 0.46886335 |
| 151 | MP0003453_abnormal_keratinocyte_physiol | 0.45587773 |
| 152 | MP0002970_abnormal_white_adipose | 0.45445354 |
| 153 | MP0003795_abnormal_bone_structure | 0.45221267 |
| 154 | MP0004782_abnormal_surfactant_physiolog | 0.44488162 |
| 155 | MP0005025_abnormal_response_to | 0.43202536 |
| 156 | MP0005451_abnormal_body_composition | 0.43000121 |
| 157 | MP0010678_abnormal_skin_adnexa | 0.42934969 |
| 158 | MP0009765_abnormal_xenobiotic_induced | 0.41213512 |
| 159 | MP0004272_abnormal_basement_membrane | 0.41131184 |
| 160 | MP0008789_abnormal_olfactory_epithelium | 0.41027757 |
| 161 | MP0002405_respiratory_system_inflammati | 0.40874090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Metabolic alkalosis (HP:0200114) | 6.31298500 |
| 2 | Increased circulating renin level (HP:0000848) | 6.24229586 |
| 3 | Hypokalemic alkalosis (HP:0001949) | 6.03249225 |
| 4 | Hyperactive renin-angiotensin system (HP:0000841) | 5.82808563 |
| 5 | Polyuria (HP:0000103) | 5.65075144 |
| 6 | Gout (HP:0001997) | 5.55862531 |
| 7 | Hypomagnesemia (HP:0002917) | 5.55157419 |
| 8 | Abnormality of chloride homeostasis (HP:0011422) | 5.32317311 |
| 9 | Abnormal urine output (HP:0012590) | 5.21800984 |
| 10 | Abnormality of renal excretion (HP:0011036) | 4.99506309 |
| 11 | Abnormal drinking behavior (HP:0030082) | 4.66843414 |
| 12 | Polydipsia (HP:0001959) | 4.66843414 |
| 13 | Abnormality of magnesium homeostasis (HP:0004921) | 4.64764744 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.49185471 |
| 15 | Hydroxyprolinuria (HP:0003080) | 4.41274554 |
| 16 | Abnormality of proline metabolism (HP:0010907) | 4.41274554 |
| 17 | Increased purine levels (HP:0004368) | 4.28388680 |
| 18 | Hyperuricemia (HP:0002149) | 4.28388680 |
| 19 | Renal salt wasting (HP:0000127) | 4.27847876 |
| 20 | Tetany (HP:0001281) | 4.25204434 |
| 21 | Hyperglycinuria (HP:0003108) | 4.17402772 |
| 22 | Hypothermia (HP:0002045) | 4.04665471 |
| 23 | Hyperaldosteronism (HP:0000859) | 4.04373878 |
| 24 | Abnormality of renin-angiotensin system (HP:0000847) | 4.01230466 |
| 25 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.77936250 |
| 26 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 3.74526152 |
| 27 | Alkalosis (HP:0001948) | 3.73118724 |
| 28 | Abnormality of purine metabolism (HP:0004352) | 3.52511488 |
| 29 | Type I diabetes mellitus (HP:0100651) | 3.52256492 |
| 30 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.31497690 |
| 31 | Hypoglycemic seizures (HP:0002173) | 3.27673013 |
| 32 | Abnormality of the nasal septum (HP:0000419) | 3.19977023 |
| 33 | Hypokalemia (HP:0002900) | 3.17421907 |
| 34 | Intrahepatic cholestasis (HP:0001406) | 3.11283396 |
| 35 | Congenital malformation of the right heart (HP:0011723) | 3.11120035 |
| 36 | Double outlet right ventricle (HP:0001719) | 3.11120035 |
| 37 | Hyperphosphatemia (HP:0002905) | 3.10576943 |
| 38 | Late onset (HP:0003584) | 3.07581131 |
| 39 | Proximal tubulopathy (HP:0000114) | 3.07557352 |
| 40 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.06841353 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.01691410 |
| 42 | Recurrent cutaneous fungal infections (HP:0011370) | 3.01691410 |
| 43 | Ketoacidosis (HP:0001993) | 3.01618186 |
| 44 | Abnormality of glycine metabolism (HP:0010895) | 3.00893978 |
| 45 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.00893978 |
| 46 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.98080010 |
| 47 | Fat malabsorption (HP:0002630) | 2.86632562 |
| 48 | Keratoconjunctivitis (HP:0001096) | 2.86272482 |
| 49 | Adrenal overactivity (HP:0002717) | 2.83118885 |
| 50 | Hypoglycemic coma (HP:0001325) | 2.82990903 |
| 51 | Rhinitis (HP:0012384) | 2.80933556 |
| 52 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.79582958 |
| 53 | Upper limb muscle weakness (HP:0003484) | 2.78532111 |
| 54 | Hypercalciuria (HP:0002150) | 2.77718371 |
| 55 | Abnormal auditory evoked potentials (HP:0006958) | 2.77502773 |
| 56 | Tongue fasciculations (HP:0001308) | 2.75671548 |
| 57 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.73206085 |
| 58 | Absence seizures (HP:0002121) | 2.72012256 |
| 59 | Abnormal pupillary function (HP:0007686) | 2.71895216 |
| 60 | Spontaneous abortion (HP:0005268) | 2.67274596 |
| 61 | Muscle fibrillation (HP:0010546) | 2.66710749 |
| 62 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.65105232 |
| 63 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.65105232 |
| 64 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.64840772 |
| 65 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.64840772 |
| 66 | Confusion (HP:0001289) | 2.63106118 |
| 67 | Chronic bronchitis (HP:0004469) | 2.62846447 |
| 68 | Renal tubular acidosis (HP:0001947) | 2.57943557 |
| 69 | Steatorrhea (HP:0002570) | 2.56525517 |
| 70 | Abnormal ciliary motility (HP:0012262) | 2.54334423 |
| 71 | Interstitial pulmonary disease (HP:0006530) | 2.51700763 |
| 72 | Abnormality of sodium homeostasis (HP:0010931) | 2.51639677 |
| 73 | Abnormality of midbrain morphology (HP:0002418) | 2.49600661 |
| 74 | Molar tooth sign on MRI (HP:0002419) | 2.49600661 |
| 75 | Chronic hepatic failure (HP:0100626) | 2.48079324 |
| 76 | Abnormality of nucleobase metabolism (HP:0010932) | 2.44995381 |
| 77 | Absent/shortened dynein arms (HP:0200106) | 2.41932013 |
| 78 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.41932013 |
| 79 | Abnormality of potassium homeostasis (HP:0011042) | 2.40530786 |
| 80 | Hypobetalipoproteinemia (HP:0003563) | 2.39319095 |
| 81 | Bicornuate uterus (HP:0000813) | 2.34892161 |
| 82 | Dehydration (HP:0001944) | 2.32752860 |
| 83 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.28845009 |
| 84 | Barrel-shaped chest (HP:0001552) | 2.25999867 |
| 85 | Ketosis (HP:0001946) | 2.24741386 |
| 86 | Hepatoblastoma (HP:0002884) | 2.24298495 |
| 87 | Tubular atrophy (HP:0000092) | 2.21247103 |
| 88 | Lip pit (HP:0100267) | 2.19490145 |
| 89 | Abnormal pancreas size (HP:0012094) | 2.18864046 |
| 90 | Generalized aminoaciduria (HP:0002909) | 2.17376194 |
| 91 | Stage 5 chronic kidney disease (HP:0003774) | 2.12758804 |
| 92 | Tachypnea (HP:0002789) | 2.11166741 |
| 93 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.09734587 |
| 94 | Prolonged partial thromboplastin time (HP:0003645) | 2.09541703 |
| 95 | Hypoplasia of the uterus (HP:0000013) | 2.09448034 |
| 96 | Truncus arteriosus (HP:0001660) | 2.08642952 |
| 97 | Metaphyseal irregularity (HP:0003025) | 2.08562177 |
| 98 | Abnormality of macular pigmentation (HP:0008002) | 2.07883815 |
| 99 | Dialeptic seizures (HP:0011146) | 2.07656061 |
| 100 | Generalized muscle weakness (HP:0003324) | 2.07646115 |
| 101 | Eczematoid dermatitis (HP:0000976) | 2.07179542 |
| 102 | Pancreatic cysts (HP:0001737) | 2.05172495 |
| 103 | Abnormality of the pubic bones (HP:0003172) | 2.05002716 |
| 104 | Vacuolated lymphocytes (HP:0001922) | 2.04831367 |
| 105 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.02550746 |
| 106 | Prolonged neonatal jaundice (HP:0006579) | 2.02236367 |
| 107 | Abnormality of the gastric mucosa (HP:0004295) | 2.01270924 |
| 108 | Nephrocalcinosis (HP:0000121) | 2.00674294 |
| 109 | Symptomatic seizures (HP:0011145) | 2.00089320 |
| 110 | Disproportionate short-trunk short stature (HP:0003521) | 1.97954802 |
| 111 | Glomerulosclerosis (HP:0000096) | 1.97849204 |
| 112 | Abnormality of macrophages (HP:0004311) | 1.97182628 |
| 113 | Enlarged kidneys (HP:0000105) | 1.96488419 |
| 114 | Myositis (HP:0100614) | 1.96343677 |
| 115 | Type 2 muscle fiber atrophy (HP:0003554) | 1.95636537 |
| 116 | Bronchiectasis (HP:0002110) | 1.94506980 |
| 117 | Hyperammonemia (HP:0001987) | 1.92770849 |
| 118 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.92511455 |
| 119 | Annular pancreas (HP:0001734) | 1.91617917 |
| 120 | Nephrolithiasis (HP:0000787) | 1.90756309 |
| 121 | Hypoplasia of dental enamel (HP:0006297) | 1.90513646 |
| 122 | Glycosuria (HP:0003076) | 1.89245700 |
| 123 | Abnormality of urine glucose concentration (HP:0011016) | 1.89245700 |
| 124 | Recurrent skin infections (HP:0001581) | 1.88644049 |
| 125 | Vascular calcification (HP:0004934) | 1.88049657 |
| 126 | Abnormality of the renal cortex (HP:0011035) | 1.87976034 |
| 127 | Chondrocalcinosis (HP:0000934) | 1.85420236 |
| 128 | Abnormal urine phosphate concentration (HP:0012599) | 1.84146650 |
| 129 | Xerostomia (HP:0000217) | 1.82388262 |
| 130 | Mitral stenosis (HP:0001718) | 1.82064740 |
| 131 | Hypolipoproteinemia (HP:0010981) | 1.81336464 |
| 132 | Recurrent fungal infections (HP:0002841) | 1.77489194 |
| 133 | Asplenia (HP:0001746) | 1.77116903 |
| 134 | Type I transferrin isoform profile (HP:0003642) | 1.76764051 |
| 135 | Tubulointerstitial nephritis (HP:0001970) | 1.76394752 |
| 136 | Amyloidosis (HP:0011034) | 1.75679863 |
| 137 | Hypoplastic ischia (HP:0003175) | 1.75091395 |
| 138 | Abnormality of alanine metabolism (HP:0010916) | 1.74296553 |
| 139 | Hyperalaninemia (HP:0003348) | 1.74296553 |
| 140 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.74296553 |
| 141 | Abnormality of the labia minora (HP:0012880) | 1.73765301 |
| 142 | Large for gestational age (HP:0001520) | 1.73119768 |
| 143 | Abnormality of the common coagulation pathway (HP:0010990) | 1.72053969 |
| 144 | Abnormality of Sharpey fibers (HP:0100685) | 1.71221730 |
| 145 | Fatigable weakness (HP:0003473) | 1.70745084 |
| 146 | Abnormality of the neuromuscular junction (HP:0003398) | 1.70745084 |
| 147 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.70420284 |
| 148 | Absent epiphyses (HP:0010577) | 1.70420284 |
| 149 | Bilateral microphthalmos (HP:0007633) | 1.70232023 |
| 150 | Short nail (HP:0001799) | 1.69971628 |
| 151 | Cystic liver disease (HP:0006706) | 1.69055864 |
| 152 | Cardiovascular calcification (HP:0011915) | 1.67582528 |
| 153 | Malnutrition (HP:0004395) | 1.66298448 |
| 154 | Abnormality of the ischium (HP:0003174) | 1.66220688 |
| 155 | Abnormality of the renal medulla (HP:0100957) | 1.65947561 |
| 156 | Hyperphosphaturia (HP:0003109) | 1.64589577 |
| 157 | Hypotension (HP:0002615) | 1.63557499 |
| 158 | Colitis (HP:0002583) | 1.63203113 |
| 159 | Bell-shaped thorax (HP:0001591) | 1.61953733 |
| 160 | Hypercortisolism (HP:0001578) | 1.61863893 |
| 161 | Right ventricular cardiomyopathy (HP:0011663) | 1.61720611 |
| 162 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.61656659 |
| 163 | Abnormality of the wing of the ilium (HP:0011867) | 1.61609876 |
| 164 | Hyperglycemia (HP:0003074) | 1.61535192 |
| 165 | Onycholysis (HP:0001806) | 1.61343780 |
| 166 | Abnormality of the fingertips (HP:0001211) | 1.60084615 |
| 167 | Muscle fiber atrophy (HP:0100295) | 1.59929640 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.19051415 |
| 2 | WNK3 | 5.03697424 |
| 3 | WNK4 | 4.84917444 |
| 4 | TRIM28 | 4.78132751 |
| 5 | OXSR1 | 4.29183380 |
| 6 | DYRK1B | 3.89597781 |
| 7 | MAP3K14 | 3.61636166 |
| 8 | INSRR | 3.52880144 |
| 9 | FGFR2 | 3.21988833 |
| 10 | TIE1 | 2.77108732 |
| 11 | PHKG2 | 2.68032647 |
| 12 | PHKG1 | 2.68032647 |
| 13 | IRAK4 | 2.55139511 |
| 14 | RIPK1 | 2.50062083 |
| 15 | IRAK3 | 2.38378427 |
| 16 | BRSK1 | 2.35397645 |
| 17 | PTK6 | 2.29563418 |
| 18 | EPHA2 | 2.22551246 |
| 19 | NUAK1 | 2.14312775 |
| 20 | ERBB3 | 2.07277652 |
| 21 | STK39 | 1.96613991 |
| 22 | AKT3 | 1.91924931 |
| 23 | PINK1 | 1.77031261 |
| 24 | NTRK3 | 1.76862491 |
| 25 | TBK1 | 1.72407825 |
| 26 | MST4 | 1.60714810 |
| 27 | PIM2 | 1.60713176 |
| 28 | KDR | 1.55197367 |
| 29 | CASK | 1.53259011 |
| 30 | FER | 1.53039425 |
| 31 | MUSK | 1.33918140 |
| 32 | EPHA4 | 1.32532564 |
| 33 | EPHB1 | 1.27244548 |
| 34 | FGFR4 | 1.26440490 |
| 35 | BMPR2 | 1.20360028 |
| 36 | PTK2 | 1.15457018 |
| 37 | ACVR1B | 1.15292843 |
| 38 | ADRBK2 | 1.14843254 |
| 39 | PAK3 | 1.12423324 |
| 40 | EIF2AK3 | 1.12251625 |
| 41 | BMPR1B | 1.10716744 |
| 42 | FLT3 | 1.09242573 |
| 43 | MAPK11 | 1.08176114 |
| 44 | PRKCI | 1.04251090 |
| 45 | PASK | 1.02596131 |
| 46 | CAMKK2 | 1.01516757 |
| 47 | BCKDK | 1.01317580 |
| 48 | MAPK15 | 1.00138033 |
| 49 | SGK494 | 0.98422901 |
| 50 | SGK223 | 0.98422901 |
| 51 | DYRK3 | 0.95669987 |
| 52 | PKN2 | 0.95199286 |
| 53 | PDK2 | 0.94580212 |
| 54 | STK3 | 0.94443522 |
| 55 | IKBKE | 0.91580803 |
| 56 | NLK | 0.91400772 |
| 57 | PIK3CA | 0.91342602 |
| 58 | IRAK1 | 0.91155513 |
| 59 | PRKAA2 | 0.89445457 |
| 60 | CDK12 | 0.88263605 |
| 61 | TGFBR1 | 0.88153780 |
| 62 | CHUK | 0.87921991 |
| 63 | NME1 | 0.86732378 |
| 64 | ERN1 | 0.86294197 |
| 65 | STK38L | 0.85608299 |
| 66 | MAP3K9 | 0.84440288 |
| 67 | BRSK2 | 0.83939221 |
| 68 | ITK | 0.82999231 |
| 69 | PNCK | 0.82389719 |
| 70 | EPHA3 | 0.77222889 |
| 71 | PLK2 | 0.72155184 |
| 72 | TEC | 0.69817313 |
| 73 | MAP2K2 | 0.69393194 |
| 74 | LRRK2 | 0.69050908 |
| 75 | BCR | 0.67165016 |
| 76 | JAK3 | 0.66240218 |
| 77 | CAMK1G | 0.66110956 |
| 78 | TRIB3 | 0.65800820 |
| 79 | TAOK3 | 0.64994275 |
| 80 | KSR1 | 0.64773859 |
| 81 | NEK1 | 0.64477847 |
| 82 | MAP3K1 | 0.64332952 |
| 83 | LATS1 | 0.63949273 |
| 84 | STK24 | 0.63550096 |
| 85 | MAP2K6 | 0.63223097 |
| 86 | PRKCQ | 0.62853079 |
| 87 | MST1R | 0.61928587 |
| 88 | MAP3K7 | 0.61333703 |
| 89 | PRKCE | 0.61262556 |
| 90 | PBK | 0.61139662 |
| 91 | STK38 | 0.60756686 |
| 92 | CAMK1D | 0.59549295 |
| 93 | MAP3K3 | 0.59516823 |
| 94 | PIK3CG | 0.59490174 |
| 95 | TSSK6 | 0.59137886 |
| 96 | EPHB2 | 0.59048965 |
| 97 | TGFBR2 | 0.57531580 |
| 98 | GRK6 | 0.56877601 |
| 99 | FGFR1 | 0.56473993 |
| 100 | PAK4 | 0.55118333 |
| 101 | MAPKAPK3 | 0.55052604 |
| 102 | PRKCG | 0.53145897 |
| 103 | GSK3A | 0.52134216 |
| 104 | PRKCD | 0.49941360 |
| 105 | PDGFRB | 0.49569612 |
| 106 | PDK3 | 0.48827936 |
| 107 | PDK4 | 0.48827936 |
| 108 | NTRK1 | 0.48817866 |
| 109 | MAP2K1 | 0.47308890 |
| 110 | TESK1 | 0.46594374 |
| 111 | FGFR3 | 0.45574239 |
| 112 | LMTK2 | 0.45545445 |
| 113 | CSNK1E | 0.43177445 |
| 114 | TYK2 | 0.41839143 |
| 115 | SGK2 | 0.41766882 |
| 116 | ADRBK1 | 0.40990745 |
| 117 | CAMK2B | 0.39413323 |
| 118 | RET | 0.39394684 |
| 119 | PRKACB | 0.38914767 |
| 120 | GRK1 | 0.37998483 |
| 121 | JAK2 | 0.37926597 |
| 122 | ROCK1 | 0.37801000 |
| 123 | CDC42BPA | 0.37632480 |
| 124 | CAMK2G | 0.37529765 |
| 125 | CDK7 | 0.36828395 |
| 126 | WNK1 | 0.36398802 |
| 127 | BTK | 0.36186948 |
| 128 | EGFR | 0.35198122 |
| 129 | GRK5 | 0.34413077 |
| 130 | CSNK2A2 | 0.32229104 |
| 131 | ERBB2 | 0.31921452 |
| 132 | CSF1R | 0.31832801 |
| 133 | SGK3 | 0.31681501 |
| 134 | PKN1 | 0.31483366 |
| 135 | IKBKB | 0.31438719 |
| 136 | ERBB4 | 0.30341558 |
| 137 | CAMK2D | 0.29037920 |
| 138 | PRKCA | 0.28299924 |
| 139 | PDK1 | 0.27901857 |
| 140 | PRKCZ | 0.27827093 |
| 141 | PRKG1 | 0.27322372 |
| 142 | STK11 | 0.27171047 |
| 143 | CSNK1A1 | 0.27033561 |
| 144 | ATM | 0.26955168 |
| 145 | IGF1R | 0.26749365 |
| 146 | MAP3K2 | 0.26699492 |
| 147 | TLK1 | 0.26539508 |
| 148 | ARAF | 0.26291776 |
| 149 | MELK | 0.26248394 |
| 150 | MET | 0.26247873 |
| 151 | CSNK1A1L | 0.25534727 |
| 152 | PTK2B | 0.25338190 |
| 153 | PRKAA1 | 0.24606588 |
| 154 | SGK1 | 0.24523137 |
| 155 | PIM1 | 0.23866654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.95453655 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 3.42439202 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.40203113 |
| 4 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.87611211 |
| 5 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.73958690 |
| 6 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.58239226 |
| 7 | Histidine metabolism_Homo sapiens_hsa00340 | 2.52638689 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.43323674 |
| 9 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.43310158 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.25342826 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.21549347 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.19008112 |
| 13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.15442663 |
| 14 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.14242774 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.01125621 |
| 16 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.90921810 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.87562218 |
| 18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.85027897 |
| 19 | Retinol metabolism_Homo sapiens_hsa00830 | 1.82682946 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.79627864 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.77905869 |
| 22 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.73534976 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.67234377 |
| 24 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.65470362 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.58330531 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.57560355 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.57119409 |
| 28 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.56853419 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.56519595 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.55828660 |
| 31 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.54269951 |
| 32 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.47120097 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.42952095 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.41068712 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.40886352 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40450413 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38279903 |
| 38 | Asthma_Homo sapiens_hsa05310 | 1.38147311 |
| 39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.37427788 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.25993173 |
| 41 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.23160395 |
| 42 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23106654 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.22684882 |
| 44 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.20059392 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13878479 |
| 46 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12902536 |
| 47 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.12640256 |
| 48 | Mineral absorption_Homo sapiens_hsa04978 | 1.12404036 |
| 49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.10707384 |
| 50 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.09318990 |
| 51 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.08107690 |
| 52 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.02390919 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 1.00622432 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99339519 |
| 55 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.98954532 |
| 56 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.93515798 |
| 57 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.92663351 |
| 58 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.90250366 |
| 59 | Taste transduction_Homo sapiens_hsa04742 | 0.88247224 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.87275836 |
| 61 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.85663443 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.85626779 |
| 63 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.85423697 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83062002 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.82719475 |
| 66 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82224418 |
| 67 | Tight junction_Homo sapiens_hsa04530 | 0.81923830 |
| 68 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.81406522 |
| 69 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.76560985 |
| 70 | Phototransduction_Homo sapiens_hsa04744 | 0.75965580 |
| 71 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.75917931 |
| 72 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.75174727 |
| 73 | Insulin secretion_Homo sapiens_hsa04911 | 0.74927579 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74754989 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.74714878 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73682444 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73678400 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73449637 |
| 79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72523760 |
| 80 | Melanoma_Homo sapiens_hsa05218 | 0.70966301 |
| 81 | Lysine degradation_Homo sapiens_hsa00310 | 0.69683928 |
| 82 | Lysosome_Homo sapiens_hsa04142 | 0.68586861 |
| 83 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67903753 |
| 84 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67723279 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63032872 |
| 86 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.62583219 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61575607 |
| 88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60718133 |
| 89 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.60387413 |
| 90 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59523447 |
| 91 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.59313524 |
| 92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58725463 |
| 93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57868390 |
| 94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57113916 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.57020861 |
| 96 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.56895192 |
| 97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.56438340 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56429779 |
| 99 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55713632 |
| 100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.55147357 |
| 101 | Leishmaniasis_Homo sapiens_hsa05140 | 0.54728580 |
| 102 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54709469 |
| 103 | Protein export_Homo sapiens_hsa03060 | 0.54299026 |
| 104 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53658605 |
| 105 | Basal transcription factors_Homo sapiens_hsa03022 | 0.53603003 |
| 106 | Homologous recombination_Homo sapiens_hsa03440 | 0.53528778 |
| 107 | Nicotine addiction_Homo sapiens_hsa05033 | 0.53149770 |
| 108 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.51223096 |
| 109 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50978769 |
| 110 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.49678590 |
| 111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49346314 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47704890 |
| 113 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.43132128 |
| 114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42931890 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.41679196 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39407018 |
| 117 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38931030 |
| 118 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.37200247 |
| 119 | Tuberculosis_Homo sapiens_hsa05152 | 0.37092162 |
| 120 | Salivary secretion_Homo sapiens_hsa04970 | 0.36798244 |
| 121 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.35952330 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35587278 |
| 123 | Phagosome_Homo sapiens_hsa04145 | 0.34564314 |
| 124 | Circadian rhythm_Homo sapiens_hsa04710 | 0.33718284 |
| 125 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.33176910 |
| 126 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.33012113 |
| 127 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.31406511 |
| 128 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31204273 |
| 129 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.31149482 |
| 130 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31005079 |
| 131 | Apoptosis_Homo sapiens_hsa04210 | 0.29672007 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | 0.28708912 |
| 133 | Legionellosis_Homo sapiens_hsa05134 | 0.28562018 |
| 134 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.28407810 |
| 135 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.26436929 |
| 136 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.23852674 |
| 137 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.22783017 |
| 138 | Hepatitis C_Homo sapiens_hsa05160 | 0.22593197 |
| 139 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.22095683 |
| 140 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.21419583 |
| 141 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.21273926 |
| 142 | Parkinsons disease_Homo sapiens_hsa05012 | 0.21004770 |
| 143 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.20645898 |
| 144 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20517700 |
| 145 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.20464715 |
| 146 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.18913659 |
| 147 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.18576364 |

